全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Convulsive Seizures Revealing Hashimoto’s Encephalopathy

DOI: 10.4236/wjns.2022.123011, PP. 105-111

Keywords: Hypothyroidism, Encephalopathy, Hashimoto’s Thyroiditis, Antithyroperoxidase Antibody

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction: Hashimoto encephalopathy (HE) is an autoimmune disease with different neurological and psychiatric characteristics. It is associated with increased thyroperoxidase autoantibodies. The diagnosis of HE is clinical and involves the detection of serum thyroperoxidase (TPO) antibodies and the exclusion of other etiologies. A clinical response to corticosteroid therapy supports the diagnosis. We report a case of HE revealed by convulsive seizures and cognitive and behavioral disorders. Observation: She is a 7-year-old child followed in a neurology unit for convulsive seizures for one year. Clinical examination performed in the endocrinology unit later found tachycardia without goiter, behavioral disorders, difficulties to concentrate as well as psychomotor agitation. Biological work up revealed subclinical hypothyroidism, positive anti-TPO antibodies with normal thyroid ultrasound and brain MRI. The cerebrospinal fluid was clear, normotensive and absence of pleocytosis. The sleep-wake electroencephalogram was well organized for her age with a paroxysmal discharge in the left parieto-temporal region. Based on these clinical, biological and morphological data, the diagnosis of HE was retained. Corticosteroid therapy with prednisone at 1 mg/kg/day was initiated for 6 weeks while reducing the dose progressively. There was a good clinical and biological progress under treatment. Conclusion: Hashimoto’s encephalopathy is a rare, but probably unrecognized entity. Over the past decades, knowledge about thyroid, brain, immunity interactions has increased. This indicates the importance of a multidisciplinary approach of endocrinologists, neurologists, psychiatrists and pediatricians for early recognition and treatment.

References

[1]  Ferracci, F., Bertiato, G. and Moretto, G. (2004) Hashimoto’s Encephalopathy: Epidemiologic Data and Pathogenetic Considerations. Journal of the Neurological Sciences, 217, 165-168.
https://doi.org/10.1016/j.jns.2003.09.007
[2]  Archambeaud, F., Galinat, S., Regouby, Y., Magy, L., Rebeyrotte, I., Vallat, J.M. and Teissier, M.P. (2001) Encéphalopathie de Hashimoto. Analyse de quatre observations. La Revue de Médecine Interne, 22, 653-659.
https://doi.org/10.1016/S0248-8663(01)00403-9
[3]  Adams, A.V., Mooneyham, G.C., Van Mater, H. and Gallentine, W. (2020) Evaluation of Diagnostic Criteria for Hashimoto’s Encephalopathy among Children and Adolescents. Pediatric Neurology, 107, 41-47.
https://doi.org/10.1016/j.pediatrneurol.2019.12.011
[4]  Chiarello, P., Talarico, V., Nicoletti, A., Rodio, B., Arcuri, P.P., Bosco, D., Gigliotti, F., Galati, M.C. and Raiola, G. (2020) Hashimoto Encephalopathy: A Case Report and A Short Revision of Current Literature: Hashimoto Encephalopathy in Pediatric Age. Acta Biomedica, 91, e2020087.
[5]  Watemberg, N., Greenstein, D. and Levine, A. (2006) Encephalopathy Associated with Hashimoto Thyroiditis: Pediatric Perspective. Journal of Child Neurology, 21, 1-5.
https://doi.org/10.1177/08830738060210010201
[6]  Graham, B.R., Shiff, N., Nour, M., Hasal, S., Huntsman, R. and Almubarak, S. (2016) Hashimoto Encephalopathy Presenting with Stroke-Like Episodes in an Adolescent Female: A Case Report and Literature Review. Pediatric Neurology, 59, 62-70.
https://doi.org/10.1016/j.pediatrneurol.2016.02.003
[7]  Castillo, P., Woodruff, B., Caselli, R., Vernino, S., Lucchinetti, C., Swanson, J., Noseworthy, J., Aksamit, A., Carter, J., Sirven, J., Hunder, G., Fatourechi, V., Mokri, B., Drubach, D., Pittock, S., Lennon, V. and Boeve, B. (2006) Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis. Archives of Neurology, 63, 197-202.
https://doi.org/10.1001/archneur.63.2.197
[8]  Chaigne, B., Beaufils, E., Jouan, Y., et al. (2012) Encéphalopathie d’Hashimoto. La Revue de Médecine Interne, 33, 390-395.
https://doi.org/10.1016/j.revmed.2012.02.009
[9]  Graus, F., Titulaer, M.J., Balu, R., Benseler, S., Bien, C.G., Cellucci, T., Cortese, I., Dale, R.C., Gelfand, J.M., Geschwind, M., Glaser, C.A., Honnorat, J., Höftberger, R., Iizuka, T., Irani, S.R., Lancaster, E., Leypoldt, F., Prüss, H., Rae-Grant, A., Reindl, M., Rosenfeld, M.R., Rostásy, K., Saiz, A., Venkatesan, A., Vincent, A., Wandinger, K.P., Waters, P. and Dalmau, J. (2016) A Clinical Approach to Diagnosis of Autoimmune Encephalitis. The Lancet Neurology, 15, 391-404.
https://doi.org/10.1016/S1474-4422(15)00401-9
[10]  Churilov, L.P., Sobolevskaia, P.A. and Stroev, Y.I. (2019) Thyroid Gland and Brain: Enigma of Hashimoto’s Encephalopathy. Best Practice & Research Clinical Endocrinology & Metabolism, 33, Article ID: 101364.
https://doi.org/10.1016/j.beem.2019.101364
[11]  Bin Attique, H., Rao, A., Haider, L. and Trivedi, R. (2019) Successful Treatment of Hashimoto Encephalopathy with Therapeutic Plasma Exchange. Therapeutic Apheresis and Dialysis, 24, 599-601.
https://doi.org/10.1111/1744-9987.13466

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133